Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-FU vs Calcipotriol Pre-treatment for PDT in Actinic Keratosis
NCT06685588Not yet recruiting
- Sponsor
- St. Vincent's University Hospital
- Start
- Jan 2025
- Primary completion
- Jan 2026
- Modality
- Orthosteric Ligands
01
Overview
Randomised, single-blind trial of AKP01 and fluorouracil 5% cream in actinic keratosis (AK) (2 arms), sponsored by St. Vincent's University Hospital. Primary endpoints: Proportion of participants with complete clearance of AKs from baseline at 6 months and Tolerability of treatment at Day 28. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
AKP01fluorouracil 5% cream
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT06685588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06685588.